AAAAAA
Results:
1-14
|
Results: 14
Authors:
Schlicker, E
Kathmann, M
Citation: E. Schlicker et M. Kathmann, Modulation of transmitter release via presynaptic cannabinoid receptors, TRENDS PHAR, 22(11), 2001, pp. 565-572
Authors:
Kathmann, M
Weber, B
Schlicker, E
Citation: M. Kathmann et al., Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice, N-S ARCH PH, 363(1), 2001, pp. 50-56
Authors:
Nickel, T
Bauer, U
Schlicker, E
Kathmann, M
Gothert, M
Sasse, A
Stark, H
Schunack, W
Citation: T. Nickel et al., Novel histamine H-3-receptor antagonists and partial agonists with a non-aminergic structure, BR J PHARM, 132(8), 2001, pp. 1665-1672
Authors:
Kathmann, M
Weber, B
Zimmer, A
Schlicker, E
Citation: M. Kathmann et al., Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice, BR J PHARM, 132(6), 2001, pp. 1169-1173
Authors:
Drutel, G
Kathmann, M
Heron, A
Gros, C
Mace, S
Schwartz, JC
Arrang, JM
Citation: G. Drutel et al., Two splice variants of the hypoxia-inducible factor HIF-1 alpha as potential dimerization partners of ARNT2 in neurons, EUR J NEURO, 12(10), 2000, pp. 3701-3708
Authors:
Nakazi, M
Bauer, U
Nickel, T
Kathmann, M
Schlicker, E
Citation: M. Nakazi et al., Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors, N-S ARCH PH, 361(1), 2000, pp. 19-24
Authors:
Molderings, GJ
Menzel, S
Kathmann, M
Schlicker, E
Gothert, M
Citation: Gj. Molderings et al., Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation, BR J PHARM, 130(7), 2000, pp. 1706-1712
Authors:
Drutel, G
Heron, A
Kathmann, M
Gros, C
Mace, S
Plotkine, M
Schwartz, JC
Arrang, JM
Citation: G. Drutel et al., ARNT2, a transcription factor for brain neuron survival?, EUR J NEURO, 11(5), 1999, pp. 1545-1553
Authors:
Kathmann, M
Bauer, U
Schlicker, E
Citation: M. Kathmann et al., CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide, N-S ARCH PH, 360(4), 1999, pp. 421-427
Authors:
Kathmann, M
Bauer, U
Schlicker, E
Gothert, M
Citation: M. Kathmann et al., Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain, N-S ARCH PH, 359(6), 1999, pp. 466-470
Authors:
Bauer, U
Nakazi, M
Kathmann, M
Gothert, M
Schlicker, E
Citation: U. Bauer et al., The stereoselective kappa-opioid receptor antagonist Mr2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor, N-S ARCH PH, 359(1), 1999, pp. 17-20
Authors:
Werthwein, S
Bauer, U
Nakazi, M
Kathmann, M
Schlicker, E
Citation: S. Werthwein et al., Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro, BR J PHARM, 127(1), 1999, pp. 300-308
Authors:
Schlicker, E
Kathmann, M
Citation: E. Schlicker et M. Kathmann, Modulation of in vitro neurotransmission in the CNS and in the retina via H-3 heteroreceptors, PHARMCHEM L, 30, 1998, pp. 13-26
Authors:
Kathmann, M
Schlicker, E
Marr, L
Werthwein, S
Stark, H
Schunack, W
Citation: M. Kathmann et al., Ciproxifan and chemically related compounds are highly potent and selective histamine H-3-receptor antagonists, N-S ARCH PH, 358(6), 1998, pp. 623-627
Risultati:
1-14
|